Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

A Responsible Take on the World’s #1 Resource

Back in October , we introduced our Stockhouse investor audience to a very different, and very profitable, kind of company that has been a market leader working to establish itself as the only primary helium producer in the world, but also as a leader in ESG practices. ...
Dave Jackson | January 7, 2022 |

Kincora Releases First Copper-Gold Assays at Mongolia Project

On September 10th Kincora Copper Ltd. (KCC:TSX.V) provided the first drilling update at its 100%-owned copper-gold porphyry projects in the Southern Gobi region of Mongolia. This update comes after an oversubscribed $6.25 million equity raising in late June. First p...
Streetwise Reports | September 24, 2019 |

Gold Bull Outlines Australian Approach to Advance Sandman

As tight capital markets force Canadian explorers to get creative with fundraising, Gold Bull Resources Corporation (TSXV:GBRC, OTC:GBRCF) has unveiled plans to look inward for sustained explorati...
Research | October 7, 2022 |

God Bless Winston

"'Success consists of going from failure to failure without loss of enthusiasm." - Sir Winston Churchill Throughout history, society has always canonized certain political, military, and religious icons for reasons seemingly obvious, but after drilling down into the fa...
Streetwise Reports | April 16, 2019 |

Central Bank Folly: Blame the Boomers

"Destroyers seize gold and leave to its owners a counterfeit pile of paper." —Ayn Rand The baby-boom generation, of which I am a less-than-proud member, blew it. There was a time long, long ago when the mention of the words "baby boomer" evoked a sense of pride of me...
Streetwise Reports | July 26, 2019 |

Lockdown

Sector expert Michael Ballanger interprets year-end investment tactics by looking back at a childhood encounter. "Gold is money; everything else is credit." —J.P. Morgan My first faithful dog Fido (circa 1963) and I used to play a game years ago before his eyes and ...
Streetwise Reports | November 27, 2019 |

January 2020 in Review: Barometric Bedlam

Back in the 1980s, I had a boss that was right out of Monty Python. A Canadian by birth, he was the son of a very wealthy English nobleman who spent a number of years in Brazil as CEO of Brazilian Traction, where he was raised by servants and nannies and attended private ...
Streetwise Reports | February 4, 2020 |

Is this stunning 'evidence' that NervGen has the goods?

This could be the signal that tiny NervGen Pharma Corp. (TSX-V:NGEN; OTCQX:NGENF) is destined to be one of the top performing biotech startup stocks this year. It came in a seemingly innocuous podcast interview about the company’s ongoing Phase 1b/2...
Knox Henderson | February 1, 2024 |

The Power of Scarcity

The fast food world gave us an interesting case study in supply and demand last week. By now you’ve no doubt heard about The Chicken Sandwich, the surprise superstar menu item from Popeyes Louisiana Kitchen that’s launched 1,000 blog post...
Frank Holmes | September 3, 2019 |

NervGen: Are amazing human trial results leaking out?

“We are very excited! We are very, very excited!” So says Dr. Monica Perez, who is running the first human trial for a potential new wonder drug being developed by a tiny but well-financed life sciences start-up, NervGen Pharma Corp. ...
Knox Henderson | July 2, 2024 |
1 2 3 4 5 6 7 8 9 10 ...